A 3-month-old baby with H1N1 and Guillain-Barré syndrome

BMJ Case Reports

Volumn , Issue , 2012, Pages

  Vasconcelos, Alexandra ^a   Abecasis, Francisco ^b   Monteiro, Rita ^c   Camilo, Cristina ^b   Vieira, Marisa ^b   De Carvalho, Mamede ^b   Correia, Manuela ^b  

^a Hospital Prof Doutor Fernando Fonseca   (Portugal)

^b HOSPITAL DE SANTA MARIA   (Portugal)

^c HOSPITAL DE SÃO FRANCISCO XAVIER   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ANTIBIOTIC AGENT; ASPARTATE AMINOTRANSFERASE; ATROPINE; IMMUNOGLOBULIN; LACTATE DEHYDROGENASE; OSELTAMIVIR;

2009 H1N1 INFLUENZA; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANTIDROMIC STIMULATION; ARTICLE; ARTIFICIAL VENTILATION; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BICEPS BRACHII MUSCLE; BODY POSTURE; BRADYCARDIA; CASE REPORT; COMORBIDITY; DISEASE COURSE; DISEASE SEVERITY; ELECTROMYOGRAPHY; EMERGENCY WARD; FEMALE; FIBEROPTIC BRONCHOSCOPY; FROG LEG POSTURE; GUILLAIN BARRE SYNDROME; HOME REHABILITATION; HOSPITAL ADMISSION; HUMAN; INFANT; INTENSIVE CARE UNIT; LACTATE DEHYDROGENASE BLOOD LEVEL; MEDIAN NERVE; MOTOR NERVE CONDUCTION; MUSCLE HYPOTONIA; OUTCOME ASSESSMENT; PERONEUS NERVE; POSTERIOR TIBIAL NERVE; PRIORITY JOURNAL; PROTEIN CEREBROSPINAL FLUID LEVEL; PROTEIN CONTENT; RESPIRATORY FAILURE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEPSIS; TENDON REFLEX; THORAX RADIOGRAPHY; TRACHEOTOMY; ULNAR NERVE; VASTUS MEDIALIS MUSCLE;

EID: 84861059298     PISSN: None     EISSN: 1757790X     Source Type: Journal    
DOI: 10.1136/bcr.12.2011.5462     Document Type: Article

References (26)

1. Agrawal S, Peake D, Whitehouse WP. Management of children with Guillain-Barré syndrome. Arch Dis Child Educ Pract Ed 2007;92:161-8.
2. Winner SJ, Evans JG. Age-specific incidence of Guillain-Barré syndrome in Oxfordshire. Q J Med 1990;77:1297-304.
3. Hughes RA, Cornblath DR. Guillain-Barré syndrome. Lancet 2005;366:1653-66.
4. Hughes RA, Hadden RD, Gregson NA, et al. Pathogenesis of Guillain-Barrésyndrome. J Neuroimmunol 1999;100:74-97.
5. Randall DP. Guillain-Barré syndrome differential diagnosis. Disease-a-month: DM 2010;56:266-78. Available from: http://www.ncbi.nlm.nih.gov/ pubmed/20493304 (accessed January 2012).
6. Lehmann HC, Hartung HP, Kieseier BC, et al. Guillain-Barré syndrome after exposure to influenza virus. The Lancet infectious diseases. 2010;10:643-51. Available from: http://www.ncbi.nlm.nih.gov/pubmed/20797646 (accessed January 2012).
7. Grimaldi-Bensouda L, Alpérovitch A, Besson G, et al.; Lucien Abenhaim for the GBS-PGRx Study Group. Guillain-Barre syndrome, influenzalike illnesses, and influenza vaccination during seasons with and without circulating A/H1N1 viruses. Am J Epidemiol 2011;174:326-35.
8. Schonberger LB, Bregman DJ, Sullivan-Bolyai JZ, et al. Guillain-Barre syndrome following vaccination in the National Influenza Immunization Program, United States, 1976-1977. Am J Epidemiol 1979;110:105-23. (Pubitemid 10209694)
9. Sejvar JJ, Uyeki TM. Neurologic complications of 2009 influenza A (H1N1): heightened attention on an ongoing question. Neurology 2010;74:1020-1.
10. The Brighton Collaboration. Immunize Safely. Basel, Switzerland: Brighton Collaboration Foundation; 2010. (http://www.brightoncollaboration.org). (accessed 25 June 2010).
11. Asbury AK, Arnason BGW, Karp HR, et al. Criteria for diagnosis of Guillain-Barré syndrome. Ann Neurol 1978;3:565-6.
12. Asbury AK, Cornblath DR. Assessment of current diagnostic criteria for Guillain-Barré syndrome. Ann Neurol 1990;27:S21-4. (Pubitemid 20178648)
13. Yuki N, Handa S, Taki T, et al. Cross-reactive antigen between nervous tissue and a bacterium elicits Guillain-Barré syndrome: molecular mimicry between gangliocide GM1 and lipopolysaccharide from Penner's serotype 19 of Campylobacter jejuni. Biomed Res 1992;13:451-53. (Pubitemid 23072771)
14. Yuki N, Taki T, Takahashi M, et al. Molecular mimicry between GQ1b ganglioside and lipopolysaccharides of Campylobacter jejuni isolated from patients with Fisher's syndrome. Ann Neurol 1994;36:791-3.
15. Aspinall GO, McDonald AG, Raju TS, et al. Chemical structures of the core regions of Campylobacter jejuni serotypes O:1, O:4, O:23, and O:36 lipopolysaccharides. Eur J Biochem 1993;213:1017-27. (Pubitemid 23152210)
16. Aspinall GO, Fujimoto S, McDonald AG, et al. Lipopolysaccharides from Campylobacter jejuni associated with Guillain-Barré syndrome patients mimic human gangliosides in structure. Infect Immun 1994;62:2122-5. (Pubitemid 24137027)
17. Neisser A, Bernheimer H, Berger T, et al. Serum antibodies against gangliosides and Campylobacter jejuni lipopolysaccharides in Miller Fisher syndrome. Infect Immun 1997;65:4038-42. (Pubitemid 27422055)
18. Stowe J, Andrews N, Wise L, et al. Investigation of the temporal association of Guillain-Barre syndrome with influenza vaccine and influenzalike illness using the United Kingdom General Practice Research Database. Am J Epidemiol 2009;169:382-8.
19. Kutlesa M, Santini M, Krajinovi V, et al. Acute motor axonal neuropathy associated with pandemic H1N1 influenza A infection. Neurocritical Care 2010;13:98-100. Available from: http://www.ncbi.nlm.nih.gov/pubmed/20428968 (accessed January 2012).
20. Verity C, Stellitano L, Winstone AM, et al. G uillain-Barré syndrome and H1N1 influenza vaccine in UK children. Lancet 2011;378:1545-6. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22035553 (accessed January 2012).
21. Oomes PG, van der Meché FG, Kleyweg RP. Liver function disturbances in Guillain-Barré syndrome: a prospective longitudinal study in 100 patients. Dutch Guillain-Barré Study Group. Neurology 1996;46:96-100. Available from: http://www.ncbi.nlm.nih.gov/pubmed/8559429 (accessed January 2012).
22. Ropper AH, Wijdicks EFM, Truax BT. Guillain-Barre syndrome. In: Contemporary Neurology Series. Vol. 34. Philadelphia, PA: FA Davis 1991.
23. van Doorn PA, Brand A, Vermeulen M. Clinical significance of antibodies against peripheral nerve tissue in infl ammatory polyneuropathy. Neurology 1987;37:1798-802.
24. Smith SA, Ouvrier R. Peripheral neuropathies in children. In: Swaiman KF, Ashwal S, eds. Paediatric Neurology Principles and Practice. Third edition. St Louis: Mosby Inc 1999.
25. CDC. Neurologic complications associated with novel influenza A (H1N1) virus infection in children - Dallas, Texas, May 2009. MMWR 2009;58:773-8.
26. Rothberg MB, Haessler SD. Complications of seasonal and pandemic influenza. Crit Care Med 2010;38(4 Suppl):e91-7.